组织恢复通过阻碍ERK酸化来缓解勒沃多巴诱导的运动障碍
Meng-Di Zhang1, Meng-Jie Gu2, Qi Wang1
1Institute of Nutrition and Diseases, School of Public Health, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
European journal of nutrition
|April 18, 2025
概括
补充剂有效地减少了帕金森病模型中的异常非自愿运动. 这种干预可能通过减少ERK酸化和天体细胞激活来起作用,为利沃多巴诱导的运动障碍症 (LID) 提供了新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 利沃多巴是帕金森病 (PD) 的首要治疗方法.
- 长期使用莱沃多巴往往导致莱沃多巴诱导的运动障碍 (LID),其特点是非自愿的运动.
- 了解LID背后的机制对于开发有效疗法至关重要.
研究的目的:
- 在小鼠模型中研究 (Zn) 补充对LID的治疗效果.
- 探索影响LID的潜在分子机制.
主要方法:
- 一种6-二多巴胺 (6-OHDA) 诱导的帕金森病模型在雄性C57BL/6J小鼠中.
- 通过每日注射利沃多巴来诱导LID.
- 在四周的时间内,给予不同剂量的 (0,0.3,1.2,2.4毫克/公斤).
主要成果:
- 补充剂使组织水平正常化,并在LID小鼠中显著减少异常非自愿运动 (AIM).
- 治疗降低了酸化谷氨酸受体1 (p-GluR1) 和细胞外信号调节激酶 (p-ERK/ERK) 的表达.
- 观察到状纤维酸蛋白 (GFAP) 和氨酸酶 (TH) 阳性细胞的剂量依赖性减少,以及AIM,p-ERK和组织之间的相关性.
结论:
- 补充剂有效地减轻了Levodopa诱导的运动障碍小鼠模型中的AIM.
- 治疗效果与抑制ERK酸化和天体细胞激活有关.
- 可以通过减少TH阳性细胞来减弱条状补偿,这表明LID的新疗法策略.
相关概念视频
Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K


